RxDoctor Payments Data

Shivaraj Patil

Clinical Cardiac Electrophysiology · Rochester, MNNPI 1023506722

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Boston Scientific at 29.6% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in MN, where the typical reported total is $10,629.

$5,037in general payments, 2019–2025

Across 89 payments — averaging $56.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Biotronik Inc.$1K
  • E.r. Squibb & Sons, L.L.C.$363
  • Medical Device Business Services, Inc.$327
  • Impulse Dynamics (USA) Inc.$272
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$210
  • plus $977 from 12 others

What the payments were for

  • Travel & lodging$2,52750%
  • Food & beverage$2,35047%
  • Education$1593%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,037 in reported general payments places this provider in the 30th percentile of 72 clinical cardiac electrophysiology providers in Minnesota.

See all clinical cardiac electrophysiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$2,189
Medicare patients
14
Services billed
15

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban27$23,397
Amiodarone Hcl24$949
Metoprolol Succinate24$240
Diltiazem 24hr Er (Cd)Diltiazem Hcl17$228

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$97$23,39727 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 72 clinical cardiac electrophysiology providers in Minnesota.

Other clinical cardiac electrophysiology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →